Creative Medical Technology Holdings, Inc.
CELZ
$3.16
-$0.035-1.10%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | 0.00% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | 0.00% | |||
| Cost of Revenue | -- | 0.00% | |||
| Gross Profit | -- | 0.00% | |||
| SG&A Expenses | -17.66% | -36.23% | |||
| Depreciation & Amortization | 0.33% | 35.40% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -24.05% | -11.92% | |||
| Operating Income | 23.91% | 11.94% | |||
| Income Before Tax | 24.71% | 11.65% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 24.71% | 11.65% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 24.71% | 11.65% | |||
| EBIT | 23.91% | 11.94% | |||
| EBITDA | 24.36% | 12.52% | |||
| EPS Basic | 42.21% | 24.04% | |||
| Normalized Basic EPS | 42.21% | 24.04% | |||
| EPS Diluted | 42.21% | 24.04% | |||
| Normalized Diluted EPS | 42.21% | 24.04% | |||
| Average Basic Shares Outstanding | 30.28% | 16.31% | |||
| Average Diluted Shares Outstanding | 30.28% | 16.31% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||